1
|
Nassar AH, El-Am E, Denu R, Abou Alaiwi S, El Zarif T, Macaron W, Abdel-Wahab N, Desai A, Smith C, Parikh K, Abbasi M, Bou Farhat E, Williams JM, Collins JD, Al-Hader A, McKay RR, Malvar C, Sabra M, Zhong C, El Alam R, Chehab O, Lima J, Phan M, Dalla Pria HF, Trevino A, Neilan TG, Kwan JM, Ravi V, Deshpande H, Demetri G, Choueiri TK, Naqash AR. Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study. JACC CardioOncol 2024; 6:71-79. [PMID: 38510282 PMCID: PMC10950431 DOI: 10.1016/j.jaccao.2023.11.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2023] [Revised: 11/13/2023] [Accepted: 11/15/2023] [Indexed: 03/22/2024] Open
Abstract
Background Primary cardiac soft tissue sarcomas (CSTS) affect young adults, with dismal outcomes. Objectives The aim of this study was to investigate the clinical outcomes of patients with CSTS receiving immune checkpoint inhibitors (ICIs). Methods A retrospective, multi-institutional cohort study was conducted among patients with CSTS between 2015 and 2022. The patients were treated with ICI-based regimens. The Kaplan-Meier method was used to estimate overall survival (OS) and progression-free survival (PFS). Objective response rates were determined according to Response Evaluation Criteria in Solid Tumors version 1.1. Treatment-related adverse events were graded per the Common Terminology Criteria for Adverse Events version 5.0. Results Among 24 patients with CSTS, 17 (70.8%) were White, and 13 (54.2%) were male. Eight patients (33.3%) had angiosarcoma. At the time of ICI treatment, 18 patients (75.0%) had metastatic CSTS, and 4 (16.7%) had locally advanced disease. ICIs were administered as the first-line therapy in 6 patients (25.0%) and as the second-line therapy or beyond in 18 patients (75.0%). For the 18 patients with available response data, objective response rate was 11.1% (n = 2 of 18). The median PFS and median OS in advanced and metastatic CSTS (n = 22) were 5.7 months (95% CI: 2.8-13.3 months) and 14.9 months (95% CI: 5.7-23.7 months), respectively. The median PFS and OS were significantly shorter in patients with cardiac angiosarcomas than in those with nonangiosarcoma CSTS: median PFS was 1.7 vs 11 months, respectively (P < 0.0001), and median OS was 3.0 vs 24.0 months, respectively (P = 0.008). Any grade treatment-related adverse events occurred exclusively in the 15 patients with nonangiosarcoma CSTS (n = 7 [46.7%]), of which 6 (40.0%) were grade ≥3. Conclusions Although ICIs demonstrate modest activity in CSTS, durable benefit was observed in a subset of patients with nonangiosarcoma, albeit with higher toxicity.
Collapse
Affiliation(s)
- Amin H. Nassar
- Yale University School of Medicine, New Haven, Connecticut, USA
| | - Edward El-Am
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | - Ryan Denu
- University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | | | - Talal El Zarif
- Dana-Farber Cancer Institute, Boston, Massachusetts, USA
| | - Walid Macaron
- University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Noha Abdel-Wahab
- University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Aakash Desai
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
| | - Caleb Smith
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
| | - Kaushal Parikh
- Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA
| | - Muhannad Abbasi
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | | | | | | | - Ahmad Al-Hader
- Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Rana R. McKay
- Moores Cancer Center, University of California-San Diego, La Jolla, California, USA
| | - Carmel Malvar
- Moores Cancer Center, University of California-San Diego, La Jolla, California, USA
| | - Mohamad Sabra
- Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Caiwei Zhong
- Dana-Farber Cancer Institute, Boston, Massachusetts, USA
| | | | - Omar Chehab
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore Maryland, USA
| | - Joao Lima
- Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore Maryland, USA
| | - Minh Phan
- Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma, USA
| | | | - Alexandra Trevino
- Department of Internal Medicine, Northwestern University, Chicago, Illinois, USA
| | - Tomas G. Neilan
- Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | | | - Vinod Ravi
- University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Hari Deshpande
- Yale University School of Medicine, New Haven, Connecticut, USA
| | - George Demetri
- Dana-Farber Cancer Institute, Boston, Massachusetts, USA
| | | | - Abdul Rafeh Naqash
- Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma, USA
| |
Collapse
|
3
|
Gouda G, D'Amico A, Abd Allah Eni A, Fayed M, Abdulaal A, Sabra M, Bogaerts M. Optimized Cement Slurry Design for Controlling Water Influx in a Gulf of Suez Egypt Salt Dome. Day 1 Mon, February 21, 2022 2022. [DOI: 10.2523/iptc-21955-ms] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/02/2023]
Abstract
Abstract
The Belayim Marine field, in the Gulf of Suez Egypt, presents many challenges to drilling operators. The most challenging section of the well is the 900-m, 16-in openhole containing a 13 5/8-in casing interval. The main risks in this section are the highly reactive salt layers in combination with high potential saltwater flow zones.
This interval is frequently drilled with a heavy 2.0-sg OBM to avoid saltwater influx during the drilling operations. Due to the mobility of the salt and unstable shale formations, the casing is run without centralizers to minimize the risks of not getting the casing to the desired section depth. Initially the interval was cemented using a 2.16-sg cement system with extended thickening time, both having the same 2.16-sg density. An external casing packer is used as an additional barrier in the event the cement placement does not achieve zonal isolation across the casing due to poor standoff.
After saltwater flow was observed at surface following the installation of the BOP, a detailed review of the casing and cementing design was performed to obtain a more robust procedure to avoid similar events in the future. Cement placement, operation design, and slurry properties were reviewed and optimized. The optimization was performed using details obtained from proprietary simulators as well as by optimizing the slurry properties in the laboratory. The cement operation design called for a single slurry scheme with very critical parameters, ensuring the cement will remain in the liquid phase to maintain applied pressure on the flow zone formations until the BOP is secured. The slurry design itself was revised and optimized in the laboratory providing right angle set along with good transition time to avoid any saltwater influx from formation fluids.
The optimized cement design and slurry properties have met all challenges. Furthermore, the new cement design in conjunction with the external casing packer succeeded in stopping the water flow influx and no similar events have occurred since the new cement operations design began being used in the field.
Collapse
|
4
|
Bou Chebl R, Jamali S, Sabra M, Safa R, Berbari I, Shami A, Makki M, Tamim H, Abou Dagher G. Lactate/Albumin Ratio as a Predictor of In-Hospital Mortality in Septic Patients Presenting to the Emergency Department. Front Med (Lausanne) 2020; 7:550182. [PMID: 33072780 PMCID: PMC7536276 DOI: 10.3389/fmed.2020.550182] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 08/19/2020] [Indexed: 12/29/2022] Open
Abstract
Background: The aim of this study is to evaluate the prognostic value of the Lactate to Albumin (L/A) ratio compared to that of lactate only in predicting morbidity and mortality in sepsis patients. Methods: This was a single-center retrospective cohort study. All adult patients above the age of 18 with a diagnosis of sepsis who presented between January 1, 2014 and June 30, 2019 were included. The primary outcome was in-hospital mortality. Results: A total of 1,381 patients were included, 44% were female. Overall in-hospital mortality was 58.4% with the mortalities of sepsis and septic shock being 45.8 and 67%, respectively. 55.5% of patients were admitted to the intensive care unit. The area under the curve value for lactate was 0.61 (95% CI 0.57–0.65, p < 0.001) and for the L/A ratio was 0.67 (95% CI 0.63–0.70, p < 0.001). The cutoff generated was 1.22 (sensitivity 59%, specificity 62%) for the L/A ratio in all septic patients and 1.47 (sensitivity 60%, specificity 67%) in patients with septic shock. The L/A ratio was a predictor of in-hospital mortality (OR 1.53, CI 1.32–1.78, p < 0.001). Conclusion: The L/A ratio has better prognostic performance than initial serum lactate for in-hospital mortality in adult septic patients.
Collapse
Affiliation(s)
- Ralphe Bou Chebl
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Sarah Jamali
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Mohamad Sabra
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Rawan Safa
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Iskandar Berbari
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Ali Shami
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Maha Makki
- Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon
| | - Hani Tamim
- Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon
| | - Gilbert Abou Dagher
- Department of Emergency Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| |
Collapse
|
5
|
Wehbe MR, Sawaya F, Sabra M, Hamadi C, Hoballah J, Haddad F. Vascular Complications in the Era of Transcatheter Treatment of Adult Structural Heart Disease: A Single-Center Early Experience. Vasc Endovascular Surg 2020; 54:504-509. [PMID: 32552506 DOI: 10.1177/1538574420934620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Transcatheter treatment is becoming the mainstay treatment for structural heart diseases (SHD) in prohibitive surgical risk patients. Recently with the encouraging results, it is being offered to regular risk patients. Peripheral vascular complications (VCs) are still inherent to these procedures due to the nature of this atherosclerotic high-risk group and the profile of the devices. This is a single-center early first year experience with such events occurring after initiating a SHD program treating severe aortic stenosis, aortic regurgitation, mitral valve prolapse and regurgitation, as well as paravalvular leaks. Out of 33 patients in this time period, 5 developed PV complications which are detailed in this article with their associated risk factors and management. These include access-related complications, closure device issues, arterial rupture post device embolization, and vessel dissection. Vascular complications of those procedures take special interest since they are associated with a worse long-term prognosis. Thus, prevention with proper planning remains of essence along with multidisciplinary management.
Collapse
Affiliation(s)
- Mohammad Rachad Wehbe
- Division of Vascular & Endovascular Surgery, Department of Surgery, American University of Beirut Medical Centre, Beirut, Lebanon
| | - Fadi Sawaya
- Division of Cardiology, Department of Internal Medicine, American University of Beirut Medical Centre, Beirut, Lebanon
| | - Mohamad Sabra
- Department of internal Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
| | - Caroline Hamadi
- Division of Vascular & Endovascular Surgery, Department of Surgery, American University of Beirut Medical Centre, Beirut, Lebanon
| | - Jamal Hoballah
- Division of Vascular & Endovascular Surgery, Department of Surgery, American University of Beirut Medical Centre, Beirut, Lebanon
| | - Fady Haddad
- Division of Vascular & Endovascular Surgery, Department of Surgery, American University of Beirut Medical Centre, Beirut, Lebanon
| |
Collapse
|